1. Home
  2. FPF vs COLL Comparison

FPF vs COLL Comparison

Compare FPF & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

FPF

First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

HOLD

Current Price

$18.14

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$34.48

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPF
COLL
Founded
2013
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FPF
COLL
Price
$18.14
$34.48
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$50.83
AVG Volume (30 Days)
119.0K
400.6K
Earning Date
01-01-0001
05-28-2026
Dividend Yield
8.08%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.73
Revenue
N/A
$780,567,000.00
Revenue This Year
N/A
$6.07
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.21
Revenue Growth
N/A
23.62
52 Week Low
$15.60
$23.23
52 Week High
$19.75
$50.79

Technical Indicators

Market Signals
Indicator
FPF
COLL
Relative Strength Index (RSI) 26.78 16.51
Support Level N/A $34.30
Resistance Level $18.95 $36.20
Average True Range (ATR) 0.19 1.59
MACD -0.10 -0.70
Stochastic Oscillator 0.80 2.18

Price Performance

Historical Comparison
FPF
COLL

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: